Skip to content
buyModerate cluster of 4

Mai-Britt Zocca bought $10k of IOBT

Chief Executive Officer at IO Biotech, Inc.. 12,500 shares at an average of $0.81, traded Dec 23, 2024, filed Dec 23, 2024.

Conviction score
46
Value
$10k
12,500 shares
Holdings after
49,891
+33% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $10k at market
    0
  • Relative to holdings
    Holdings up 33%
    +6
  • Price context
    No price history yet
    0
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000905148-24-003412, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 23, 2024POpen-market purchase
Common Stock
+12,500$0.81$10k49,891Dec 23, 2024

Related signals

Other insiders at IO Biotech, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
IOBTbuy
IO Biotech, Inc.
Heidi Hunter
director
$21k
15,000 shares
-
43Moderate
IOBTbuy 4
IO Biotech, Inc.
Qasim Iftikhar Ahmad
Chief Medical Officer
$27k
31,350 shares
-
40Moderate
IOBTbuy 4
IO Biotech, Inc.
Devin Whittemore Smith
General Counsel
$9,720
12,000 shares
+243%
40Moderate
IOBTbuy 4
IO Biotech, Inc.
Amy Sullivan
Chief Financial Officer
$8,483
10,250 shares
+14%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mai-Britt Zocca bought $10k of IOBT | InsiderTell